Reply: Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial: Interpret With Caution. Zahger D, Schwartz GG, Szarek M, Fazio S, et al. J Am Coll Cardiol 2025;85:e55.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zahger D, Schwartz GG, Szarek M, Fazio S, et al. Reply: Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial: Interpret With Caution. J Am Coll Cardiol 2025;85:e55.
PMID: 39880549